DocGo Investor Presentation Deck
Q1 2023 FINANCIAL UPDATE
($ in millions)
$117.9
$79.9
Q1 2022
DOCGO
$109.5
$81.5
Q2 2022
Total Revenue
© 2023 All Rights Reserved - DocGo
Revenue
$104.4
$99.2
$108.8$107.8
Q3 2022
Q4 2022
■ Revenue Ex Covid Testing
11 DIGI
●
• ~40.2% increase in Q1 2023 total revenue over the prior
year period, exclusive of COVID testing revenue.
12
$113.0$112.0
||||
Q1 2023
GO
DI
DOCGO
Q1 2023 Financial Highlights
Total Q1 2023 revenue was $113 million, as compared to
$117.9 for the comparable period in 2022.
Adjusted EBITDA was $5.6 million
Mobile Health revenue for Q1 2023 was $72.9 million as
compared to $90.1 million for Q1 2022. Excluding mass
COVID testing revenue form both periods, Mobile Health
revenue increased 38% as compared to Q1 2022.
●
●
Transportation Services revenue was $40.1 million
compared to $27.8 million for Q1 2022, an increase of 44%
Q1 2023 Business Highlights
●
●
●
●
●
●
Announced partnership with Redirect Health for affordable,
on-demand urgent mobile healthcare to patients in NJ/NY.
Currently expect to provide remote patient and device
monitoring for >50,000 patients by end of 2023.
Activated Mobile Health contract with State of
Tennessee that utilizes DocGo's mobile clinic at Dollar
General locations.
Awarded a "911 to telemedicine" program by FDNY for
telemedicine support of select calls.
Partnered with BioFourmis to combine BioFourmis' virtual
care approach with DocGo's in-home care delivery model to
improve outcomes for customers and patients.
Awarded a large, statewide population health contract
covering a substantial number of lives in NY.
beooe
D
Boc
GO
19
→View entire presentation